Reoperation und Mortalität nach wiederholter zytoreduktiver Chirurgie mit hyperthermer intraperitonealer Chemotherapie: Ergebnisse der StuDoQ-Datenbank

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00035638

Enrollment

8116

Registered

2025-04-03

Start date

2025-04-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C78.6

Interventions

Group 1: Repeated cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - All patients who were treated with cytoreduction and HIPEC for peritoneal metastatic disease or peritoneal mesothelioma and were included in the StuDoQ|HIPEC registry

Exclusion criteria

Exclusion criteria: - Patient age < 18 years

Design outcomes

Primary

Measure	Time frame
Number of repeat surgeries due to complications during the hospital stay	—

Secondary

Measure	Time frame
30-day mortality	—

Countries

Germany

Contacts

Public ContactLukas Pollmann

Allgemein- und Viszeralchirurgie des Klinikums Dortmund

Lukas.pollmann@klinikumdo.de+49 231 953 - 2143

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026